Aortic valve replacement for severe aortic stenosis or aortic insufficiency with advanced left ventricular dysfunction

S Chris Malaisrie*, Patrick M McCarthy

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Aortic valve replacement (AVR) is the standard treatment for patient with severe, symptomatic aortic stenosis. Transcatheter aortic valve implantation (TAVI) is the new standard of therapy for those patients that are unsuitable for open heart surgery. In patients considered to be high risk secondary to severe comorbidities, TAVI may be an acceptable alternative to AVR. Future applications of transcatheter heart valves include intermediate-risk patients and failed bioprosthetic valves.

Original languageEnglish (US)
Title of host publicationSurgical Treatment for Advanced Heart Failure
PublisherSpringer New York
Pages49-61
Number of pages13
ISBN (Electronic)9781461469193
ISBN (Print)146146918X, 9781461469186
DOIs
StatePublished - Jul 1 2013

Fingerprint

Aortic Valve Stenosis
Left Ventricular Dysfunction
Aortic Valve
Heart Valves
Thoracic Surgery
Comorbidity
Therapeutics
Transcatheter Aortic Valve Replacement

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@inbook{7596b8b6261c45058cace2448a2c5be5,
title = "Aortic valve replacement for severe aortic stenosis or aortic insufficiency with advanced left ventricular dysfunction",
abstract = "Aortic valve replacement (AVR) is the standard treatment for patient with severe, symptomatic aortic stenosis. Transcatheter aortic valve implantation (TAVI) is the new standard of therapy for those patients that are unsuitable for open heart surgery. In patients considered to be high risk secondary to severe comorbidities, TAVI may be an acceptable alternative to AVR. Future applications of transcatheter heart valves include intermediate-risk patients and failed bioprosthetic valves.",
author = "Malaisrie, {S Chris} and McCarthy, {Patrick M}",
year = "2013",
month = "7",
day = "1",
doi = "10.1007/978-1-4614-6919-3_5",
language = "English (US)",
isbn = "146146918X",
pages = "49--61",
booktitle = "Surgical Treatment for Advanced Heart Failure",
publisher = "Springer New York",
address = "United States",

}

Aortic valve replacement for severe aortic stenosis or aortic insufficiency with advanced left ventricular dysfunction. / Malaisrie, S Chris; McCarthy, Patrick M.

Surgical Treatment for Advanced Heart Failure. Springer New York, 2013. p. 49-61.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Aortic valve replacement for severe aortic stenosis or aortic insufficiency with advanced left ventricular dysfunction

AU - Malaisrie, S Chris

AU - McCarthy, Patrick M

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Aortic valve replacement (AVR) is the standard treatment for patient with severe, symptomatic aortic stenosis. Transcatheter aortic valve implantation (TAVI) is the new standard of therapy for those patients that are unsuitable for open heart surgery. In patients considered to be high risk secondary to severe comorbidities, TAVI may be an acceptable alternative to AVR. Future applications of transcatheter heart valves include intermediate-risk patients and failed bioprosthetic valves.

AB - Aortic valve replacement (AVR) is the standard treatment for patient with severe, symptomatic aortic stenosis. Transcatheter aortic valve implantation (TAVI) is the new standard of therapy for those patients that are unsuitable for open heart surgery. In patients considered to be high risk secondary to severe comorbidities, TAVI may be an acceptable alternative to AVR. Future applications of transcatheter heart valves include intermediate-risk patients and failed bioprosthetic valves.

UR - http://www.scopus.com/inward/record.url?scp=84929548780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929548780&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6919-3_5

DO - 10.1007/978-1-4614-6919-3_5

M3 - Chapter

SN - 146146918X

SN - 9781461469186

SP - 49

EP - 61

BT - Surgical Treatment for Advanced Heart Failure

PB - Springer New York

ER -